• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

ASCO Audio Journal of Oncology – June 4th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of Julie Gralow

0
  • by alexperjescuadmin
  • in AJO · ASCO · Oncology
  • — 3 Jun, 2006
ASCO Audio Journal of Oncology - June 4th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of Julie Gralow
AudioMedica News
ASCO Audio Journal of Oncology - June 4th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of Julie Gralow
ASCO Audio Journal of Oncology - June 4th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of Julie Gralow
00:00 /
RSS Feed
Share
Link
Embed
Julie Gralow
Julie Gralow
Charles Geyer
Charles Geyer
Judith Bliss
Judith Bliss
Robert Coleman
Robert Coleman

Julie Gralow, from the Fred Hutchinson Cancer Research Center in Seattle, joins Derek Thorne to talk about the latest news from the ASCO annual meeting in Atlanta.

– In women with advanced HER2/neu positive breast cancer, lapatinib plus capecitabine is better than capecitabine alone and could be recommended for compassionate use. Charles Geyer, from Allegheny General Hospital in Pittsburgh, presented the data to the ASCO meeting in a Scientific Special Session
– Postmenopausal women with breast cancer may benefit from a switching strategy, where tamoxifen is replaced by exemestane after two to three years – that’s according to the Intergroup Exemestane Study, presented by Judith Bliss of the Institute of Cancer Research in London (Late Breaking Abstract 527)
– Is the higher bone loss associated with anastrozole a concern? Robert Coleman, of Sheffield University, presented bone mineral density data from the ATAC study, which compared anastrozole and tamoxifen in postmenopausal women (Abstract 511)


[audio:https://www.audiomedica.com/podcasting/asco/06.06.04_ASCO_podcast.mp3]
Share

Tags: anastrozolebreastcapecitabineinterviewslapatinibtamoxifen

You may also like...

  • Audio Journal of Oncology in Advance – January 15th, 2007 – HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer Audio Journal of Oncology in Advance – January 15th, 2007 – HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer 17 Jan, 2007
  • Gender Disparity in Head and Neck Cancer Treatment and Outcomes Gender Disparity in Head and Neck Cancer Treatment and Outcomes 9 Jun, 2018
  • ASCO Audio Journal of Oncology in Advance – June 1st, 2007 – reporting from: American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles ASCO Audio Journal of Oncology in Advance – June 1st, 2007 – reporting from: American Association for Cancer Research Centennial Meeting, April 14-18, Los Angeles 2 Jun, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Audio Journal of Oncology – June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of George Canellos
  • Next story ASCO Audio Journal of Oncology – June 5th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • New Front Line Standard for Older Patients with…
    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Genomically Targeted Therapy Delays Advanced Breast…
    • Palbociclib Combination Prolongs Life After Breast…
  • Home
  • Oncology
  • AJO
  • ASCO Audio Journal of Oncology – June 4th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of Julie Gralow

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.